MOTS-c: Mitochondrial-Derived Peptides and Metabolic Regulation

Key Takeaways

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene (MT-RNR1), representing the first identified mitochondrial-derived peptide (MDP) with direct nuclear signaling activity, capable of translocating to the nucleus under metabolic stress to regulate adaptive gene expression in cell culture models.
In murine myocyte and hepatocyte models, MOTS-c activates AMP-activated protein kinase (AMPK) through disruption of the folate-methionine cycle and subsequent accumulation of the de novo purine synthesis intermediate AICAR, establishing a metabolic signaling axis distinct from canonical energy-sensing pathways.
Administration of MOTS-c in aged mouse models recapitulates multiple hallmarks of exercise adaptation, including improved insulin sensitivity, enhanced fatty acid oxidation, increased skeletal muscle glucose uptake, and resistance to diet-induced weight gain, earning it classification as an exercise mimetic peptide in the preclinical literature.
Endogenous MOTS-c levels decline with age in rodent tissue assays, and this decline correlates with diminished mitochondrial function and metabolic flexibility, positioning MOTS-c as a molecule of significant interest in aging and metabolic research.

Introduction

The mitochondrial genome, a 16,569-base-pair circular DNA molecule encoding 13 oxidative phosphorylation subunits, 22 transfer RNAs, and 2 ribosomal RNAs, was long considered fully annotated. The discovery of MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) in 2015 by Lee et al. revised this assumption by demonstrating that short open reading frames (sORFs) within mitochondrial ribosomal RNA genes encode bioactive peptides with potent regulatory functions [1]. MOTS-c is a 16-amino-acid peptide derived from the MT-RNR1 gene, and its identification established a new class of signaling molecules: mitochondrial-derived peptides (MDPs).

While the MDP humanin, encoded within the mitochondrial 16S rRNA gene, had previously demonstrated cytoprotective properties in neuronal cell culture models, MOTS-c was the first MDP shown to function as a systemic metabolic regulator capable of translocating from the cytoplasm to the nucleus, where it directly influences gene expression under metabolic stress [2]. This retrograde signaling capacity positions MOTS-c at the interface of mitochondrial biology and nuclear transcriptional control, a communication axis central to metabolic homeostasis and cellular aging.

This article examines the molecular characterization of MOTS-c, its AMPK activation mechanism, exercise mimetic properties in animal models, and role in stress response and cellular resilience in preclinical systems.

Mitochondrial-Derived Peptides: A New Class of Signaling Molecules

Mitochondrial-derived peptides represent a paradigm shift in the understanding of mitochondrial function. The mitochondrial genome was historically viewed as a minimalist coding unit dedicated exclusively to oxidative phosphorylation components. The discovery that sORFs embedded within ribosomal RNA genes produce functional peptides has expanded the informational capacity of the mitochondrial genome considerably [1].

Three MDP families have been identified: humanin (encoded by MT-RNR2), MOTS-c (encoded by MT-RNR1), and the small humanin-like peptides (SHLPs 1 through 6, also within MT-RNR2). Each exhibits distinct tissue distribution and functional profiles in preclinical models. Humanin signals through the formyl peptide receptor-like 1 (FPRL1) and a trimeric receptor complex comprising CNTFR, WSX-1, and gp130, while SHLPs modulate mitochondrial respiration and apoptosis through mechanisms under active investigation [3].

MOTS-c is distinguished from other MDPs by several features. It circulates in plasma and is detectable in skeletal muscle, brain, liver, and adipose tissue in rodent models. Most critically, it exhibits the unique capacity for stress-dependent nuclear translocation, enabling direct regulation of nuclear gene expression in response to metabolic perturbation, a property that sets it apart from classical mitochondrial signals such as reactive oxygen species (ROS) or the mitochondrial unfolded protein response (UPRmt) [2]. Evolutionary conservation of the MOTS-c coding sequence across mammalian species suggests strong selective pressure to maintain this peptide, though polymorphisms in the MT-RNR1 gene have motivated population-level genotypic analyses [4].

MOTS-c: Encoded by the 12S rRNA Gene

The MOTS-c peptide is translated from a sORF located within the MT-RNR1 gene on the heavy strand of the mitochondrial genome. The 48-nucleotide coding sequence begins at position 1541 and encodes the 16-amino-acid peptide MRWQEMGYIFYPRKLR. In cell-free translation assays and in-vitro transcription-translation systems, this sORF produces a peptide detectable by mass spectrometry and immunoassay, confirming its status as a genuine gene product rather than a bioinformatic artifact [1].

The biosynthetic pathway involves mitochondrial transcription and translation, with subsequent export to the cytoplasm through mechanisms not yet fully resolved. Evidence from HEK293T cell studies suggests that MOTS-c can be released into the extracellular environment, acting in both autocrine and paracrine signaling capacities. Plasma concentrations have been quantified in rodent models using ELISA, with circulating levels demonstrating diurnal variation and significant decline with age [5].

Within the cytoplasm, MOTS-c targets enzymes in the folate cycle. Under conditions of metabolic stress, including glucose deprivation, oxidative challenge, and serum starvation in cell culture models, MOTS-c undergoes nuclear translocation. Immunofluorescence microscopy in HEK293T and C2C12 myoblast cells has demonstrated that MOTS-c accumulates in the nucleus within 30 to 60 minutes of stress exposure, co-localizing with chromatin and participating in transcriptional regulation through interactions with antioxidant response element (ARE)-containing gene promoters [2].

AMPK Activation and Metabolic Signaling

The central metabolic signaling mechanism of MOTS-c operates through activation of AMP-activated protein kinase (AMPK), the master energy-sensing kinase that coordinates cellular responses to energy deficit. However, the route by which MOTS-c activates AMPK is mechanistically distinct from canonical energy depletion. Rather than directly altering the AMP:ATP ratio through interference with mitochondrial electron transport, MOTS-c disrupts the folate-methionine cycle, leading to accumulation of the de novo purine biosynthesis intermediate 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), a well-characterized endogenous AMPK activator [1].

In L6 rat myocyte and HepG2 hepatocyte cultures, MOTS-c exposure produces a dose-dependent increase in intracellular AICAR concentrations within 4 to 8 hours of treatment. This AICAR accumulation is accompanied by phosphorylation of AMPK at threonine-172, the canonical activating site, and subsequent phosphorylation of downstream AMPK substrates including acetyl-CoA carboxylase (ACC) and the tuberous sclerosis complex 2 (TSC2). Pharmacological inhibition of AMPK with compound C (dorsomorphin) attenuates MOTS-c-mediated effects on glucose uptake and fatty acid oxidation in these cell models, confirming the AMPK dependence of the metabolic response [6].

Downstream of AMPK activation, MOTS-c enhances glucose transporter type 4 (GLUT4) translocation to the plasma membrane in differentiated C2C12 myotubes, increases mitochondrial fatty acid beta-oxidation as measured by palmitate oxidation assays, and suppresses de novo lipogenesis through ACC phosphorylation. In murine hepatocyte primary cultures, MOTS-c reduces expression of lipogenic transcription factors SREBP-1c and ChREBP while upregulating PPARa target genes involved in fatty acid catabolism [6].

Notably, MOTS-c-mediated AMPK phosphorylation persists for 12 to 24 hours in treated myocyte cultures, substantially longer than transient activation produced by synthetic AICAR or metformin in comparable systems, suggesting either continuous pathway engagement or induction of a positive feedback loop involving endogenous AICAR production [1].

Folate-Methionine Cycle Regulation

The mechanism connecting MOTS-c to AICAR accumulation and AMPK activation involves direct interference with one-carbon metabolism, specifically the folate cycle and its interconnected methionine cycle. In metabolomic profiling studies of MOTS-c-treated HEK293T cells, Lee et al. identified significant perturbation of folate cycle intermediates, including reduced levels of 5-methyltetrahydrofolate (5-mTHF) and 10-formyltetrahydrofolate (10-fTHF), within 6 hours of peptide exposure [1].

The folate cycle provides one-carbon units essential for de novo purine and thymidylate synthesis. MOTS-c inhibits flux through this cycle upstream of the 10-fTHF-dependent transformylase reactions required for purine ring assembly. When this pathway is impeded, AICAR accumulates because the two formylation steps required to convert it to inosine monophosphate (IMP) are compromised. This metabolic bottleneck is the proximal trigger for AMPK activation [6].

The methionine cycle is coupled to the folate cycle through methionine synthase, which requires 5-mTHF as a methyl donor to regenerate methionine from homocysteine. Disruption of folate metabolism by MOTS-c therefore reduces S-adenosylmethionine (SAM) production, the principal cellular methyl donor. Metabolomic data from treated cell cultures demonstrate reduced SAM:SAH ratios, indicating a shift in cellular methylation capacity that may contribute to epigenetic reprogramming effects observed in MOTS-c-treated cells, though precise mechanisms remain under investigation [7].

Supplementation with exogenous folate or formate partially rescues AICAR accumulation and attenuates AMPK activation in MOTS-c-treated cell cultures, providing mechanistic confirmation that the folate cycle is the primary target mediating the metabolic effects of this peptide [1].

Exercise Mimetic Properties in Animal Models

Among the most compelling preclinical findings surrounding MOTS-c is its capacity to recapitulate physiological adaptations normally associated with endurance exercise. In murine studies, systemic MOTS-c administration produced improvements in insulin sensitivity, glucose tolerance, fatty acid oxidation, and resistance to diet-induced obesity that paralleled adaptations in exercise-trained control animals [1].

In HFD-fed C57BL/6J mice, MOTS-c administration prevented diet-induced weight gain, reduced hepatic lipid accumulation, and improved glucose tolerance as assessed by intraperitoneal glucose tolerance testing. These effects were accompanied by increased AMPK and ACC phosphorylation in skeletal muscle and liver tissue, consistent with the in-vitro signaling data [1].

Aged mouse studies have yielded particularly notable results. In 22-month-old C57BL/6N mice, MOTS-c administration improved treadmill endurance performance, enhanced glucose disposal during insulin tolerance testing, and reversed the age-associated decline in skeletal muscle AMPK activity. Transcriptomic analysis of skeletal muscle from treated aged mice revealed upregulation of gene sets associated with mitochondrial biogenesis, oxidative phosphorylation, and fatty acid metabolism, overlapping substantially with the transcriptional signature of endurance exercise training in young animals [8].

The exercise mimetic classification is further supported by fiber-type composition studies. In rodent models, chronic MOTS-c exposure promotes a shift toward oxidative (type I and type IIa) fiber characteristics, including increased mitochondrial density and capillary-to-fiber ratio, hallmarks of aerobic exercise adaptation that position MOTS-c as a molecule of particular interest in sarcopenia and age-related metabolic decline research [8].

Stress Response and Cellular Resilience

Beyond its metabolic signaling functions, MOTS-c plays a role in the integrated cellular stress response. Under conditions of glucose restriction, oxidative stress, or genotoxic challenge in cell culture systems, MOTS-c undergoes rapid nuclear translocation, where it participates in a transcriptional program that enhances cellular resilience [2].

In the nucleus, MOTS-c co-localizes with regions of open chromatin enriched for antioxidant response elements. ChIP-seq analysis in HEK293T cells subjected to glucose deprivation revealed that nuclear MOTS-c associates with promoter regions of genes encoding antioxidant enzymes, including heme oxygenase-1 (HMOX1), NQO1, and glutamate-cysteine ligase catalytic subunit (GCLC). These are canonical targets of the Nrf2 transcriptional pathway, suggesting functional convergence between MOTS-c nuclear activity and Nrf2-mediated antioxidant defense [2].

In C2C12 myoblast cultures exposed to hydrogen peroxide-induced oxidative stress, MOTS-c pre-treatment reduced protein carbonylation and lipid peroxidation while maintaining mitochondrial membrane potential. These cytoprotective effects were abolished by siRNA-mediated knockdown of AMPK alpha subunits, confirming that stress resilience conferred by MOTS-c operates through AMPK-dependent mechanisms [9].

The age-related decline in endogenous MOTS-c levels, documented across multiple tissues in rodent aging studies, correlates with progressive deterioration of mitochondrial function and declining stress tolerance. In skeletal muscle from aged mice, MOTS-c protein levels decrease by approximately 50 to 60 percent compared to young adult controls, paralleling declines in mitochondrial DNA copy number and respiratory chain complex activity [5]. This correlation has generated significant interest in MOTS-c as both a biomarker of mitochondrial fitness and a mechanistic link between mitochondrial decline and the broader aging phenotype in preclinical models [10].

Summary

MOTS-c represents a fundamentally new category of biological signaling molecule: a mitochondrial-encoded peptide that functions as a systemic metabolic regulator with direct nuclear transcriptional control. Its mechanism of action, operating through folate-methionine cycle disruption, AICAR accumulation, and sustained AMPK activation, is distinct from other known AMPK activators and provides a unique tool for investigating the intersection of one-carbon metabolism, energy sensing, and gene expression in preclinical systems.

The exercise mimetic properties of MOTS-c in aged and diet-challenged murine models, encompassing improvements in insulin sensitivity, fatty acid oxidation, endurance capacity, and skeletal muscle gene expression, position this peptide at the center of ongoing research into metabolic adaptation and age-related decline. Its stress-responsive nuclear translocation and engagement with antioxidant gene programs extend its relevance to cellular resilience and mitochondrial quality control. As endogenous MOTS-c levels decline with age across multiple tissues, the regulatory biology of this peptide continues to inform preclinical investigations into the molecular mechanisms underlying metabolic homeostasis and the aging process.

References

Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454.
Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-derived peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28(3):516-524.e7.
Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796-809.
Fuku N, Pareja-Galeano H, Zempo H, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14(6):921-923.
D’Souza RF, Woodhead JST, Zeng N, et al. Circulatory levels of MOTS-c decline with age in humans and are restored by physical activity. Physiol Rep. 2020;8(13):e14497.
Ming W, Lu G, Xin S, et al. Mitochondria-related peptide MOTS-c suppresses hepatic lipogenesis and improves fatty acid oxidation via AMPK activation. Biochem Biophys Res Commun. 2016;478(4):1416-1422.
Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020;319(4):E659-E666.
Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613-6621.
Zempo H, Kim SJ, Fuku N, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide MOTS-c. Aging (Albany NY). 2021;13(2):1692-1717.

For Research Use Only. Not for human consumption. This article is intended for educational and informational purposes related to preclinical research. Stillwater BioLabs does not condone or promote the use of peptides for human use of any kind.